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ABSTRACT
Objective: The present study was aimed to evaluate the antihyperglycemic activity and in vivo antioxidant effect of methanolic extract of whole plant 
of Psydrax dicoccos (MEPD) belonging to the family Rubiaceae.
Methods: MEPD was prepared by Soxhlet extraction. Wistar rats weighing (180–200 g) were divided into six groups (n=6), with three doses of 
100 mg/kg, 200 mg/kg, and 400 mg/kg of extract. Metformin was used as a standard drug. Diabetes was induced by streptozotocin (STZ) 
(40–50 mg/kg, i.p) in control group. The animals were treated with different doses of extracts for 21 days, and on the 22nd day, the blood glucose levels 
along with antioxidant enzymes such as superoxide dismutase (SOD), catalase (CAT), and lipid peroxidase (LPO) were determined.
Results: The phytochemical screening of the extract showed the presence of carbohydrates, phenolics, flavonoids, glycosides, and tannins. The methanolic 
extract of MEPD at the dose of 200 mg/kg body weight showed a significant reduction in blood glucose levels (**p<0.001) with the value of 151.2 mg/dl 
on the 22nd day at 8 h. A promising antioxidant effect was also evident from the determination of antioxidant enzymes such as SOD, CAT, and LPO.
Conclusion: The P. dicoccos extract revealed a potential effect of antihyperglycemic activity and combating nature on oxidative stress induced by STZ.
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INTRODUCTION
Diabetes mellitus is a metabolic disorder characterized by hyperglycemia 
with hampered metabolism of vital biological components such as 
carbohydrate, protein, and lipids. The effects are mainly due to the 
defective insulin secretion, loss of insulin receptors, or both [1]. Earlier 
century in India, two physicians “Charaka and Susruta” reported 
the disease. However, in the 18th–19th century, hyperglycemia is less 
visualized clinically, identified by uncontrolled glycosuria, and usually 
diagnosed in later stage of life; currently, it is recognized as type 2 
diabetes mellitus. Persistent higher blood glucose levels generate free 
radicals that may lead to the development of oxidative stress in distinct 
parts of the body which further culminate to various complications such 
as cardiovascular, neurodegenerative, chronic kidney failure, ocular 
damage, and vascular diseases [2]. Free radicals are highly unstable 
reactive oxygen species (ROS) produced regularly in various normal 
biological reactions in the human system. Whenever these free radicals 
are produced, their effects are monitored by defense system of the body 
which includes antioxidant enzymes such as superoxide dismutase 
(SOD), catalase (CAT), glutathione peroxidase, glutathione reductase 
(GR), and lipid peroxidase (LPO) [3]. This “oxidative shielding” acts 
as a protective mechanism to counter the attack of toxic pathogens 
or noxious chemicals or to destruct the cell by apoptosis and thus 
preventing its advancement to neighboring cells [4]. The term “oxidative 
stress” is biological state in which ROS and RNS level attain a maximum 
peak, either by excess production or insufficient removal. Since ROS and 
RNS have been a highly reactive molecule, it will cause some alteration 
to vital biological proteins, carbohydrates, DNA, lipids, and other 
molecules, further prelude to physiological dysfunction of cells and 
pathologic condition such as diabetes, heart diseases, and cancer [5].
Antioxidants are the compounds that can prevent (or) inhibit oxidation 
chain reaction process in living cells [6]. The use of synthetic agents is 
frequently associated with several undesirable side effects and fails to 
correct the fundamental biochemical lesion and diabetic complications. 
From the researcher’s point of view, investigation on medicinal plants 
has gained importance because of their natural origin and fewer side 
effects [6]. New therapies are needed which control the hyperglycemic 
condition and prevent long-term complications. Although there are 
drugs which were reported to control blood glucose levels of diabetic 
subjects/animal models, these failed to control complications of 
diabetes because of side/toxic effects such as hepatotoxicity or cardiac 
failure. Therefore, authentic evaluation is needed for herbal drug with 
an expectation of product efficacy, safety, and therapeutic risk/benefit. 
Hence, the current research aims to scientifically investigate the 
traditionally used medicinal plants in the treatment of diabetes mellitus, 
their insulin secretagogue action, and potent antioxidant effect.
Psydrax dicoccos Gaertn. (Syn. Canthium dicoccum [Gaertn.]) belongs 
to the family Rubiaceae and the plant is found in all parts of tropical 
regions of India. It is an unarmed shrub, grows up to 3 m tall. All the plant 
parts have been recognized to have medicinal properties such as anti-
inflammatory, digestive, anti-necrotic, hepatoprotective, neuroprotective, 
and antioxidant property. It is also used for fever and also applied as 
plasters; decoction of the root is used in diarrhea. Bark powder with 
sesame oil is used in rheumatic pains. Used in inflammation, during 
night boiled leaf extract is taken for 2 months [7]. A number of flavonoids 
have been shown to suppress carcinogenesis in various animal models. 
Flavonoids are also responsible as effective scavengers, which participate 
in antioxidant mechanism. The present study was taken up to evaluate the 
antihyperglycemic property and antioxidant effect of whole plant extract 
(methanolic) of P. dicoccos streptozotocin (STZ)-induced diabetic rats [8].
METHODS
Collection of plant material and preparation of extract [9]
The whole plant P. dicoccos was procured from Tirumala Hills, 
Tirupati, and was authenticated by Dr. Madhava Chetty, Botanist, Sri 
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Venkateshwara University, Tirupati, Andhra Pradesh. The plant material 
was powdered and extracted with methanol in a Soxhlet apparatus at a 
temperature of 60°C for 12 h. The resultant extract was filtered, and the 
filtered extract was then concentrated to dryness in a rotary evaporator 
under reduced pressure and stored in a desiccator.
Preparation of extract
Suspension of methanolic extract of Psydrax dicoccos (MEPD) was 
prepared in 0.1% dimethyl sulfoxide as a suspending agent. The extract 
was administered at three doses of 100, 200, and 400 mg/kg, respectively.
Preliminary phytochemical analysis
The MEPD was screened for the presence of various phytoconstituents 
such as alkaloids, carbohydrates, phenolics, flavonoids, glycosides, and 
tannins.
Acute toxicity studies [10]
Albino rats weighing 150–250 g were selected by random sampling 
technique and used for the study. Acute oral toxicity was performed as 
per OECD-423 guidelines (acute class method). The animals were fasted 
overnight, provided only water after which extract was administered to the 
groups orally at the dose level of 5 mg/kg body weight by gastric intubation, 
and the groups were observed for 14 days. If mortality was observed in 
two or three animals, among six animals, then the dose administered was 
assigned as a toxic dose. If mortality was observed in one animal, then the 
same dose was repeated again to confirm the toxic dose.
If mortality was not observed, the procedure was repeated for further 
higher doses such as 50, 300, and 2000 mg/kg body weight. The 
animals were observed for toxic symptoms such as behavioral changes, 
locomotion, convulsions, and mortality for 72 h. It was observed that 
the test extract was not mortal even at a dose of 2000 mg/kg body 
weight. Hence, 250 mg/kg and 500 mg/kg doses were selected for the 
study.
Animals
Adult male rats of Wistar albino strain weighing between 150 and 
200 g were obtained from our college animal house. They were kept 
in polypropylene cages with not more than five animals per cage and 
allowed to get acclimatized to a standard laboratory diet. The animals 
were adapted to laboratory condition before the experiments at 
constant room temperature of 22±1°C temperature with 12 h light and 
dark cycle. Feed (standard pellets) and drinking water were provided 
ad libitum. The experimental protocol was duly approved by the 
Institutional Animal Ethical Committee (IAEC) of Committee for the 
Purpose of Control and Supervision of Experimentation on animals 
through its reference no: IAEC/SVCP/2016/007, Dated: 27/2/16.
Induction of experimental diabetes [11]
Induction of experimental diabetes: Diabetes was induced by a 
single intraperitoneal injection of a freshly prepared STZ solution 
(Sisco Research Laboratories Pvt., Ltd., Mumbai-93, India) (Batch 
No: T-835796) (Dose: 30–50mg/kg) in citrate buffer 0.1 M, pH 4.5 to 
overnight fasted rats. Diabetes was identified by polydipsia, polyuria, 
and by measuring blood glucose levels 48 h after injection of STZ. 
Animals which did not develop more than 250 mg/100 ml of blood 
glucose levels were rejected.
Experimental design
The experiment was carried out in six groups of six rats each:
Group I: Normal control rats received saline
Group II: Diabetic control (DC)
Group III: DC + Metformin (50 mg/kg)
Group IV: DC + MEPD (100 mg/kg)
Group V: DC + MEPD (200 mg/kg)
Group VI: DC + MEPD (400 mg/kg).
Diabetes was induced by administering STZ and the animals of 
Groups IV, V, and VI were treated with the extracts at specified doses for 
21 days. On the 22nd day, the blood was withdrawn from retro-orbital 
plexus and centrifuged serum glucose levels were estimated on at 0 h, 
1 h, 2 h, 4 h, 6 h, and 8 h, respectively, by glucose oxidase method, and 
absorbance was measured at 505 nm by UV spectrophotometer [12]. At 
the end of the experimental period, the animals were deprived of food 
overnight and sacrificed by decapitation. The liver was removed and 
homogenized for in vivo antioxidant activity.
In vivo antioxidant activities
Lipid peroxidation is based on the reaction of malondialdehyde (MDA) 
one of the products of lipid peroxidation with thiobarbituric acid to 
form thiobarbituric acid reactive substances, which has a pink color 
with absorption maxima at 540 nm [13]. CAT activity was determined 
according to the method of Aebi [14]. SOD activity was determined 
calorimetrically by the method of Kono [15]. Ascorbic acid was taken 
as a standard agent.
Statistical analysis
The results are expressed as mean±standard deviation. Comparison 
between the groups was made by analysis of variance, followed by 
Dunnett’s test as per suitability. p<0.001 was considered statistically 
significant. Statistical calculations were done using GraphPad Prism 
version 6.0.
RESULTS AND DISCUSSION
From ancient times, diabetic patients have used medicinal plants to 
maintain blood glucose level. In this regard, the present study was 
extended to show the influence of extracts on the blood glucose levels 
and oxidative stress.
The preliminary phytochemical analysis showed that MEPD was found 
to possess various phytoconstituents such as carbohydrates, phenolics, 
flavonoids, glycosides, and tannins, whereas alkaloids were absent.
MEPD (200 mg/kg) and metformin (50 mg/kg) showed significant 
(p<0.001) fall in blood glucose levels at 1 h, 2 h, 4 h 6 h, and 8 h, 
respectively, when compared with DC group (Table 1).
Table 2 shows the effect of administration of MEPD on MDA, CAT, and 
SOD in liver tissue of different groups of rats. There was a significant 
(p<0.001) elevation in tissue MDA in diabetic rats as compared to normal 
Table 1: Effect of MEPD on blood glucose levels in diabetic rats
Treatment and dose Serum glucose levels (mg/dl)
0 h 1 h 2 h 4 h 6 h 8 h
Normal 94.4±3.8 86.5±3.21 91.3±2.03 82.9±0.85 85±0.36 82.6±0.95
DC 268.5±5.5** 272.2±3.95** 280.9±3.26** 281±4.78** 275.8±1.14** 271.3±1.14**
DC+Metformin (50 mg/kg) 280±7.3 262±3.45 152.3±4.08** 138.3±1.82** 137±0.51** 129.1±0.98**
DC+MEPD (100 mg/kg) 270±9.01 255.6±3.08 250.1±2.2 261.2±2.62 251.6±1.22 259±2.62
DC+MEPD (200 mg/kg) 275.6±3.48 250.6±6.67* 185.5±3.66** 165.87±3.01** 160.02±2.1** 150.6±1.27**
DC+MEPD (400 mg/kg) 270.6±3.66 255.8±3.66* 250.78±2.67 245.07±1.68 240.8±1.12 240.67±1.67
The data are expressed in mean±S.E.M, n=6 in each group, **p<0.001, significant, compared to DC. MEPD: Methanolic extract of Psydrax dicoccos, DC: Diabetic control, 
SEM: Standard error of the mean
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rats. Treatment with MEPD at a dose of 200 mg/kg for 21 days resulted 
in significant (p<0.001) decrease in liver tissue MDA. CAT and SOD in DC 
rats were significantly (p<0.001) depleted in liver tissue when compared 
to normal rats. MEPD treatment at a dose of 200 mg/kg significantly 
(p<0.001) restored CAT and SOD levels as compared to DC rats.
In the present study, we examined the effects of MEPD on oxidative 
stress and β-cell damage in STZ-induced diabetic rats. Diabetics and 
experimental models exhibit high oxidative stress due to persistent 
and chronic hyperglycemia, which causes depletion of antioxidative 
defense system and promote de novo generation of free radicals. STZ is 
most commonly used to induce diabetes in rats. This causes the death 
of pancreatic β-cell by alkylation of DNA resulting in reduced synthesis 
and release of insulin. This results in fragmentation of DNA by means of 
production of ROS. STZ causes massive destruction of β-cells of the islets 
of Langerhans resulting in the insulin synthesis and secretion [16]. The 
toxic effect of STZ is not restricted to abolishment of pancreatic β-cells 
but also causes oxidative stress. Continuous exposure of the system to 
free radicals results in decreased activities of SOD and CAT.
The results presented in Table 1 indicated that P. dicoccos plant extract 
produced antihyperglycemic activity in a dose-dependent manner. 
Further, at a dose of 200 mg/kg, the extract produced significant 
antihyperglycemic activity when compared with the reference 
compound metformin. Here, the glucose lowering activity of P. dicoccos 
may be attributed to both pancreatic (enhancement of insulin secretion) 
and extrapancreatic (peripheral utilization of glucose) mechanisms.
The present data indicated that STZ-induced diabetes disrupts the 
actions of antioxidant enzymes. The decreased activities of these 
enzymes may be due to the production of ROS such as superoxide (O2·-), 
hydrogen peroxide (H2O2), and hydroxyl radical (·OH) that reduced the 
activity of these enzymes [11]. In the present study, MEPD potentiated 
the in vivo antioxidant activities. Elevation of LPO is attributed to the 
enhanced production of the ROS. In the present study, we observed 
an MDA formation, the index of lipid peroxidation was significantly 
increased in the liver of STZ-treated animals. MEPD supplementation 
potentially reduced MDA level, suggesting that MEPD might have 
antioxidant principles to produce such a response. CAT and SOD 
protect the cellular system against the toxic effects of lipid peroxidation. 
A marked depletion in both the enzymes of a liver was observed in DC 
rats (Table 2). Furthermore, MEPD treatment showed a significant 
restoration in CAT and SOD of diabetic rats.
In the present study, findings showed positive effect of P. dicoccos on rats 
with STZ-induced disturbances in the glucose level and the antioxidant 
status. Thus, MEPD is beneficial in the control of diabetes and oxidative 
stress by activation of enzymatic antioxidants.
CONCLUSION
The result of the present study indicates that P. dicoccos may have 
active principle(s) which are responsible for the potent antidiabetic 
activity. However, more efforts are still required for the isolation, 
characterization, and biological evaluation of the active principle(s) of 
P. dicoccos extract.
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